Bodman banned for anti-doping violation-ZoomTech News


Charley Bodman performed at Hunslet earlier than becoming a member of fellow League One facet Cornwall RLFC final yr

Rugby league participant Charley Bodman has been banned for 18 months by UK Anti-Doping to be used of a banned substance.

The 22-year-old, who most not too long ago performed at Cornwall RLFC, examined optimistic for terbutaline in an out-of-competition pattern on 25 April.

Bodman admitted the cost however mentioned utilization was not “intentional”, which was accepted by UKAD.

His ban was lowered from the usual two-year suspension, however he will be unable to play till 25 November 2024.

Terbutaline is used to forestall bronchospasm in sufferers with bronchial asthma, bronchitis, emphysema and different lung illnesses.

Bodman mentioned he had been prescribed it to deal with bronchial asthma, however was required to use for a therapeutic use exemption (TUE) prematurely of taking it.

He utilized for a retrospective TUE however that was denied by UKAD’s Equity Evaluation Panel and he was charged with the violation on 8 September.

“Medicines prescribed by a physician or purchased over-the-counter might comprise prohibited substances. It’s an athlete’s duty to test their treatment earlier than utilizing it, even when they’ve used it earlier than,” UKAD’s director of operations, Hamish Coffey, mentioned.

“It’s also crucial that athletes test whether or not they’re included in UKAD’s Nationwide TUE Pool and to know that, if they’re, they’re required to use for a TUE prematurely of utilizing treatment that comprises a prohibited substance.”

The Wales-born second-row joined League One facet Cornwall in June 2022 and made 16 appearances for the membership.

He beforehand performed for Yorkshire facet Hunslet.

A press release from the Rugby Soccer League added: “The RFL works with RL Cares, the game’s impartial charity, to make sure help is on the market for gamers in circumstances akin to this.”

Watch on iPlayer bannerWatch on iPlayer footer


Leave a Comment

Your email address will not be published. Required fields are marked *

Scroll to Top